Christoph U. Correll, MD, PhD
a:3:{i:0;s:116:"Department of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Uniondale, New York";i:1;s:71:"Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, New York";i:2;s:93:"Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany";}
Narrative Review
Alternative Treatment for Agitation in Schizophrenia and Bipolar Disorder
January 30, 2024
While oral and intramuscular formulations of pharmacologic agents continue to be commonly used to treat acute agitation, novel agents with alternative routes of delivery are becoming available.
Original Research
Outcome Predictors in Youth With Mental Disorders
December 27, 2023
This retrospective analysis of clinical parameters in youth hospitalized for psychiatric treatment assessed magnitude and correlates of symptom response, global illness response, social functioning, out-of-home placement, and length of...
Original Research
Olanzapine/Samidorphan Mitigates Weight Gain in Early Illness
March 22, 2023
In patients with early-phase schizophrenia or bipolar disorder, combination olanzapine and samidorphan resulted in less weight gain at week 12 than olanzapine alone. Antipsychotic efficacy was similar between the...
